Intergalactic Therapeutics, a non-viral gene therapy biotech, lays off all employees
Non-viral gene therapy maker Intergalactic Therapeutics has laid off all workers, according to an employee’s post on LinkedIn, just weeks after the biotech said it would start clinical trials next year for certain conditions that lead to blindness.
The Cambridge, MA-based biotech now seeks a buyer, the Boston Business Journal reported Tuesday afternoon. On June 27, Intergalactic had said it would bring its gene therapy IG-002 into Phase I studies next year based on data from a non-human primate study.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.